keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tabersonine hydrochloride 是分离自蔷薇中的一种吲哚类生物碱,具有抗炎活性,可用于 ALI/ARDS 的研究。Tabersonine 能破坏 Aβ(1-42) 的聚合和改善 Aβ 聚集诱导的细胞毒性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 333 | 现货 | ||
10 mg | ¥ 482 | 现货 | ||
25 mg | ¥ 796 | 现货 | ||
50 mg | ¥ 1,170 | 现货 | ||
100 mg | ¥ 1,730 | 现货 | ||
500 mg | ¥ 3,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 375 | 现货 |
产品描述 | TABERSONINE HYDROCHLORIDE is a natural product extracted from the bean of Voacanga africana, is a potent inhibitor against Aβ(1 42) aggregation and toxicity. |
体内活性 | TABERSONINE HYDROCHLORIDE is an indole alkaloid mainly isolated from Catharanthus roseus, and a potential drug candidate for treatment of cancer and Alzheimer's disease (AD), however, its anti-inflammatory effect has not been revealed.TABERSONINE HYDROCHLORIDE ameliorated lipopolysaccharides (LPS)-induced ALI in vivo and inhibited LPS-mediated macrophage activation in vitro. By using murine ALI model, we found that TABERSONINE HYDROCHLORIDE significantly attenuated LPS-induced pathological injury in the lung. TABERSONINE HYDROCHLORIDE also inhibited LPS-mediated neutrophil infiltration, elevation of MPO activity and the production of TNF-α, IL-6 and IL-1β. Furthermore, TABERSONINE HYDROCHLORIDE inhibited LPS-induced the production of pro-inflammatory mediators such as iNOS, NO and cytokines by suppressing NF-κB and p38 MAPK/MK2 signaling cascades. TABERSONINE HYDROCHLORIDE HYDROCHLORIDE reduced the K63-linked polyubiquitination of TRAF6. Taken together,TABERSONINE HYDROCHLORIDE has anti-inflammatory activities in vitro and in vivo, and is a potential therapeutic candidate for the treatment of ALI/ARDS[1]. |
别名 | 水甘草碱盐酸盐, 它波宁盐酸盐 |
分子量 | 372.89 |
分子式 | C21H25ClN2O2 |
CAS No. | 29479-00-3 |
keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (107.27 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6818 mL | 13.4088 mL | 26.8176 mL | 67.0439 mL |
5 mM | 0.5364 mL | 2.6818 mL | 5.3635 mL | 13.4088 mL | |
10 mM | 0.2682 mL | 1.3409 mL | 2.6818 mL | 6.7044 mL | |
20 mM | 0.1341 mL | 0.6704 mL | 1.3409 mL | 3.3522 mL | |
50 mM | 0.0536 mL | 0.2682 mL | 0.5364 mL | 1.3409 mL | |
100 mM | 0.0268 mL | 0.1341 mL | 0.2682 mL | 0.6704 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
TABERSONINE HYDROCHLORIDE 29479-00-3 Neuroscience Beta Amyloid 水甘草碱盐酸盐 Tabersonine TABERSONINE Hydrochloride inhibit Inhibitor 它波宁盐酸盐 LI/ARDS Aβ(1-42) inhibitor